Tom 15, Nr 2 (2022)
Artykuł przeglądowy
Opublikowany online: 2022-06-30
DOAC — not for everyone, and sometimes at different dose
Journal of Transfusion Medicine 2022;15(2):150-153.
Streszczenie
Direct oral anticoagulants (DOACs) are used in Europe over a decade. One of their favourable properties is a stable prophylactic or therapeutic drug dose. Sometimes, however, it is preferred to use older antithrombotic drugs (vitamin K antagonists, heparins) or — in some clinical situations — to modify the standard recommended drug dose.
Słowa kluczowe: direct oral anticoagulant inhibitorstreatmentatrial fibrillationantiphospholipid syndromekidney diseasevenous thromboembolism